Genomics for Surgeons: A Review with Applications to Breast, Lung, Gastrointestinal and Pediatric Cancers (C)
This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer.
Advances in genomics have led to practice-changing activity for surgeons and their patients, and impressive results in the treatment of cancers that previously had dismal prognoses. A fundamental understanding of the science is useful for practicing surgeons. This knowledge equips a physician to explain the utility of the testing and the implications for treatment. The session will begin with an overview of genomics, molecular pathology, whole genome and whole exosome sequencing, ctDNA (circulating tumor DNA) analysis, and other gene-based assays.
- Genomics for Surgeons: An Overview of Relevant Molecular Biology Platforms
Genevieve M. Boland, MD, PhD, FACS, Boston, MA
- How Are Genomics Relevant to the Practicing Breast Cancer Surgeon?
Lee G. Wilke, MD, FACS, Madison, WI
- How Are Genomics Relevant to the Practicing Lung Cancer Surgeon?
Jay M. Lee, MD, FACS, Los Angeles, CA
- How Are Genomics Relevant to the Practicing Gastrointestinal Surgeon?
Steven K. Libutti, MD, FACS, Bronx, NY
- How Are Genomics Relevant to the Practicing Melanoma Surgeon?
John R. Hyngstrom, MD, FACS, Salt Lake City, UT
- How Are Genomics Relevant to the Practicing Pediatric Surgeon?
Andrew M. Davidoff, MD, FACS, Memphis, TN
- Practicing surgeons
- Apply new knowledge and ideas to improve their surgical practice
- Adapt concepts and quality measures in support of research advancements
- Enhance the quality of patient care
- For questions about the course content, please contact firstname.lastname@example.org.
- If you have any technical questions, contact email@example.com.
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website: http://www.accme.org/requirements/accreditation-requirements-cme-providers/policies-and-definitions/financial-relationships-and-conflicts-interest
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.
(Download the full list of disclosures.)
Faculty and Disclosures
Genevieve M. Boland, MD, PhD, FACS, Boston, MA -Takeda Pharmaceuticals: Research Funding: MGH PI
Lee G. Wilke, MD, FACS, Madison, WI -Arqule Inc.: Shareholder
Jay M. Lee, MD, FACS, Los Angeles, CA - Genentech: LOI for research support (drug only) for NIH clinical trial: Principal Investigator, Genentech: Travel/Expense Reimbursement: Co-Chair of Thoracic Surgery and Member, Steering Committee
Steven K. Libutti, MD, FACS, Bronx, NY -Sorrento Therapeutics: Consulting fee: Scientific Advisory Board, AAVP Biosystems, Inc.: Equity: Board of Directors
John R. Hyngstrom, MD, FACS, Salt Lake City, UT -Ebix Inc.: Stipend: Contracted article reviewer
Andrew M. Davidoff, MD, FACS, Memphis, TN - No Disclosures
Program Committee and Disclosures
CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - No Disclosures
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - No Disclosures
David C. Borgstrom, MD, FACS, Morgantown, WV - No Disclosures
Daniel L. Dent, MD, FACS, San Antonio, TX - No Disclosures
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Audra A. Duncan, MD, FACS, London, ON - No Disclosures
Mariam F. Eskander, MD, Boston, MA - No Disclosures
Paula Ferrada, MD, FACS, Richmond, VA - No Disclosures
Neil H. Hyman, MD, FACS, Chicago, IL - No Disclosures
Martin S. Karpeh, Jr., MD, FACS, New York, NY - No Disclosures
Dennis H. Kraus, MD, FACS, New York, NY - No Disclosures
Kenneth W. Sharp, MD, FACS, Nashville, TN - No Disclosures
David A. Spain, MD, FACS, Stanford, CA - No Disclosures
Mary T. Hawn, MD, FACS, Stanford, CA - No Disclosures
Daniel M. Herron, MD, FACS, FASBMS, New York, NY - No Disclosures
Barbara Lee Bass, MD, FACS, FRCS(Hon), Houston, TX - No Disclosures
Quan-Yang Duh, MD, FACS, San Francisco, CA - No Disclosures
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - No Disclosures
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - No Disclosures
Valerie W. Rusch, MD, FACS, New York, NY - No Disclosures
Note: Residents will receive a Certificate of Completion.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Certificate of Completion
- 1.50 Self Assessment Credit